Multiple Sclerosis Info
View Article  Early Interferon Beta-1b Treatment Thwarts MS Progression

U.S. FDA Approves Betaseron(R) (Interferon beta-1b) for Use After the First Event Suggestive of Multiple Sclerosis

 

Early Treatment With Betaseron Significantly Delayed the Time ...   more »

View Article  Early Treatment With Betaseron Significantly Delayed the Time to a Second Clinical Event
Using interferon beta-1b (Betaseron) therapy in patients with the first clinical symptoms of MS (MS) significantly postpones the development of   more »
View Article  Patients Treated With Betaseron(R) After First MS Attack

Landmark Study in The Lancet:

 

Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

 

 WAYNE, N.J.,

 ...   more »